Similar articles

• In the lymelight: law and clinical practice guidelines.

  Ronn S. Ronn S. South Med J. 2009 Jun;102(6):626-30. doi: 10.1097/SMJ.0b013e3181a5dcce. South Med J. 2009. PMID: 19434013 Review.
• Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism.

  Auwaerter PG, Bakken JS, Dattwyler RJ, Dumler JS, Halperin JJ, McSweegan E, Nadelman RB, O'Connell S, Sood SK, Weinstein A, Wormser GP. Auwaerter PG, et al. J Med Ethics. 2011 Feb;37(2):68-73. doi: 10.1136/jme.2009.032896. Epub 2010 Nov 21. J Med Ethics. 2011. PMID: 21097940
• Cure unwanted? Exploring the chronic Lyme disease controversy and why conflicts of interest in practice guidelines may be guiding us down the wrong path.

  Ferguson J. Ferguson J. Am J Law Med. 2012;38(1):196-224. Am J Law Med. 2012. PMID: 22497097 No abstract available.
• Final report of the Lyme disease review panel of the Infectious Diseases Society of America.

  Lantos PM, Charini WA, Medoff G, Moro MH, Mushatt DM, Parsonnet J, Sanders JW, Baker CJ. Lantos PM, et al. Clin Infect Dis. 2010 Jul 1;51(1):1-5. doi: 10.1086/654809. Clin Infect Dis. 2010. PMID: 20504239
• Updates and controversies in the treatment of Lyme disease.

  Mitty J, Margolius D. Mitty J, et al. Med Health R I. 2008 Jul;91(7):219, 222-3. Med Health R I. 2008. PMID: 18705223 Review. No abstract available.